Antigenic compositions and methods
Multilayer films are described that include polypeptide epitopes and a toll-like receptor ligand. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
1. A composition comprising
a first multilayer film comprising a plurality of oppositely charged polyelectrolyte layers, wherein one of the polyelectrolyte layers in the multilayer film comprises a first antigenic polyelectrolyte, wherein the first antigenic polyelectrolyte comprises a covalently linked viral, bacterial, fungal or parasite polypeptide epitope,
wherein the multilayer film comprises a toll-like receptor (TLR) ligand covalently linked to the first antigenic polyelectrolyte, wherein the toll-like receptor ligand is not a lipoprotein or a lipopeptide, and
wherein the polyelectrolytes in the multilayer film comprise a polycationic material or a polyanionic material having a molecular weight of greater than 1,000 and at least 5 charges per molecule.
2. The composition of claim 1 wherein the first antigenic polyelectrolyte is a polypeptide.
3. The composition of claim 1 , wherein the first multilayer film is deposited on a core particle.
4. The composition of claim 1 , further comprising a second multilayer film comprising a plurality of oppositely charged polyelectrolyte layers, wherein one of the layers in the second multilayer film comprises a second antigenic polyelectrolyte,
wherein the second antigenic polyelectrolyte comprises a viral, bacterial, fungal or parasite polypeptide epitope, wherein the first and second antigenic polyelectrolytes comprise different polypeptide epitopes from the same or different organisms.
5. The composition of claim 4 , wherein the first and second antigenic polyelectrolytes are polypeptides.
6. The composition of claim 5 , wherein the first and second multilayer films are deposited onto core particles.
7. The composition of claim 1 , wherein the first multilayer film is deposited on a core particle comprising the TLR ligand.
8. The composition of claim 1 , wherein the TLR ligand binds the TL3, TLR4, TLR5, TLR7, TLR8 or TLR 9 receptor.
9. The composition of claim 1 , wherein the TLR ligand monophospholipid A, imiquimod, or a combination thereof.
10. The composition of claim 1 , comprising two or more different TLR ligands.
11. A method of eliciting an immune response in a vertebrate organism comprising administering into the vertebrate organism the composition of claim 1 .